[1]
D. Harshini, “Therapeutic Considerations for Docetaxel and Paclitaxel in Metastatic Breast Cancer”, J. Drug Delivery Ther., vol. 10, no. 1-s, pp. 196–204, Feb. 2020, doi: 10.22270/jddt.v10i1-s.3852.